🇺🇸 FDA
Patent

US 6511847

Recombinant p53 adenovirus methods and compositions

expired A61KA61K38/00A61K38/1709

Quick answer

US patent 6511847 (Recombinant p53 adenovirus methods and compositions) held by The Board of Regents of the University of Texas System expires Mon Jan 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00, A61K38/1709, A61K48/00, A61P